NCT03887663Recruiting
Chinese PD Registry
The Chinese Parkinson's Disease Registry
Source: ClinicalTrials.gov · Last updated 13 Dec 2019 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of the Chinese Parkinson's disease Registry (CPDR) is to develop a database of patients with Parkinson's disease in China.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 2 Dec 2018
- Start date
- 1 Feb 2017
- Primary completion date
- 1 Feb 2027
- Lead sponsor
- Xiangya Hospital of Central South University
- Diseases
- Parkinson disease
- NCT number
- NCT03887663
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 1 Feb 2017 to the primary completion date, 1 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Lack of capacity to consent to participate in the project
Who the study is looking for
- Patients diagnosed with PD by UK Brain Bank Diagnostic Criteria and other standard criteria.
Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xiangya Hospital of Central South University Coordinator of this site? Confirm its status | Changzhi | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.